Nav
Journal
J Med Econ
Volume
14
Issue
2
Pages
167-78
Publication year
2011
Suggested citation
Broder MS, Chang EY, Bentley TG, Juday T, Uy J. Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. J Med Econ. 2011; 14(2): 167-78.
DOI
10.3111/13696998.2011.554932
PMID
21288058